Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily characterized by insulin resistance, β-cell dysfunction, and impaired ...

In addition, its PYY agonist gut hormone could be combined with its metabolic hormone incretin in patients who aren’t losing enough weight or need to lose more after they have reached weight ...